Charles Schwab Investment Management Inc. Raises Stock Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

Charles Schwab Investment Management Inc. raised its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 8.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 834,417 shares of the company’s stock after acquiring an additional 61,671 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Surgery Partners were worth $17,665,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also modified their holdings of the company. FMR LLC raised its holdings in shares of Surgery Partners by 3.1% during the 3rd quarter. FMR LLC now owns 18,311,867 shares of the company’s stock worth $590,375,000 after acquiring an additional 546,869 shares in the last quarter. Janus Henderson Group PLC raised its holdings in shares of Surgery Partners by 27.5% during the 3rd quarter. Janus Henderson Group PLC now owns 5,497,368 shares of the company’s stock worth $177,235,000 after acquiring an additional 1,184,450 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Surgery Partners by 2.4% during the 3rd quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company’s stock worth $60,117,000 after acquiring an additional 42,897 shares in the last quarter. King Street Capital Management L.P. purchased a new stake in shares of Surgery Partners during the 3rd quarter worth approximately $46,748,000. Finally, E. Ohman J or Asset Management AB raised its holdings in shares of Surgery Partners by 40.3% during the 4th quarter. E. Ohman J or Asset Management AB now owns 1,243,111 shares of the company’s stock worth $26,317,000 after acquiring an additional 357,023 shares in the last quarter.

Insiders Place Their Bets

In other news, insider Marissa Brittenham sold 3,156 shares of the stock in a transaction on Monday, March 10th. The stock was sold at an average price of $24.09, for a total transaction of $76,028.04. Following the transaction, the insider now owns 63,408 shares of the company’s stock, valued at approximately $1,527,498.72. This represents a 4.74 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Harrison R. Bane sold 56,315 shares of the stock in a transaction on Friday, February 7th. The stock was sold at an average price of $25.64, for a total value of $1,443,916.60. Following the transaction, the insider now directly owns 107,037 shares in the company, valued at $2,744,428.68. The trade was a 34.47 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 106,622 shares of company stock worth $2,717,860 over the last quarter. Company insiders own 2.30% of the company’s stock.

Surgery Partners Stock Performance

SGRY stock opened at $24.36 on Thursday. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99. The business’s fifty day simple moving average is $23.79 and its two-hundred day simple moving average is $25.88. Surgery Partners, Inc. has a twelve month low of $19.50 and a twelve month high of $33.97. The firm has a market cap of $3.11 billion, a price-to-earnings ratio of -50.75, a PEG ratio of 19.21 and a beta of 2.73.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Monday, March 3rd. The company reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.01. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The business had revenue of $864.40 million for the quarter, compared to analyst estimates of $828.09 million. Analysts predict that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on SGRY. Bank of America began coverage on Surgery Partners in a report on Monday, December 16th. They set a “buy” rating and a $30.00 price target on the stock. JPMorgan Chase & Co. decreased their price target on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a report on Tuesday, December 3rd. Macquarie decreased their price target on Surgery Partners from $34.00 to $33.00 and set an “outperform” rating on the stock in a report on Tuesday, March 11th. Finally, Royal Bank of Canada decreased their price target on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a report on Wednesday, November 20th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $36.63.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.